Forensic Analysis · Professional & Commercial Services · as of Aug 13, 2026
Optimizerx Corp (OPRX)
A forensic read on Optimizerx Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
C · Mixed — selective
Forensic grade
Safe
Financial health
3.4
Distress distance
Clean
Earnings quality
5
Forensic signals
4.0%
ROE
18.8%
Revenue growth
The financial-health reading above compares this company's equity at BOOK value, not at what the market currently pays for it — this free snapshot doesn't pull live market data. Treat it as a rough read, not the final word.
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Optimizerx Corp earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 3.4, placing it in the Safe zone (based on book value, not market value, since this free snapshot doesn't pull live market data — treat this zone as a rough read, not the final word). 5 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
6.3%
FY2025
Return on invested capital.Return on invested capital is 6.3% in the latest fiscal year and rising from -9% — well below its ~10% cost of capital, and it has been across FY2011–FY2025, so reinvested dollars have not been earning their keep.
+2.2%/yr
FY2022–FY2025
Share-count dilution.Diluted share count changed +7% over the last 3 years to FY2025 (+2.2%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. Note: the share count shows a large one-time jump around FY2017, consistent with a reverse split or bankruptcy reorg rather than gradual buybacks, so the earlier shrinkage doesn't reflect real repurchase discipline. That's ~2.2% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~6%.
6% of rev
FY2025
Stock-based comp load.Stock-based compensation ran 6% of revenue and 37% of free cash flow in FY2025 — about $0.37 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 2.3% a year and that rate is not falling, so total profit has to grow by that much annually before any of it reaches a share. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.
FCF ($7M)
FY2023
Shareholder returns.Returned $8M to shareholders (buybacks + dividends) in FY2023, but free cash flow was ($7M) after capex — there was no free cash flow to fund the payout from at all, and operating cash flow itself was negative or zero that year too. The entire return is coming from debt or cash reserves, not cash the business itself generated — a harder case than returns merely running ahead of free cash flow, since here there was none to run ahead of.
Key fundamentals
Latest Revenue$109.4M
Revenue Growth YoY+18.8%
Revenue CAGR (3yr)+20.6%
Net Margin4.7%
Free Cash Flow$18.7M
Return on Equity4.0%
Debt / Equity0.20x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Optimizerx Corp's actual 10-K/10-Q/8-K filings?
Goodwill impairments.Took $7M of goodwill writedowns across 1 year (FY2024 ($7M)). Writedowns mean past acquisitions underperformed what was paid for them.